- A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer. Reckamp, K.L., Krysan, K., Morrow, J.D., Milne, G.L., Newman, R.A., Tucker, C., Elashoff, R.M., Dubinett, S.M., Figlin, R.A. Clin. Cancer Res. (2006)